Search results
Results from the WOW.Com Content Network
In acute viral hepatitis, the GGT levels can peak at 2nd and 3rd week of illness, and remained elevated at 6 weeks of illness. GGT is also elevated in 30% of the hepatitis C patients. GGT can increase by 10 times in alcoholism. GGT can increase by 2 to 3 times in 50% of the patients with non-alcoholic liver disease.
This is a shortened version of the fourth chapter of the ICD-9: Diseases of the Blood and Blood-forming Organs. It covers ICD codes 280 to 289. The full chapter can be found on pages 167 to 175 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.
This is a shortened version of the first chapter of the ICD-9: Infectious and Parasitic Diseases. It covers ICD codes 001 to 139 . The full chapter can be found on pages 49 to 99 of Volume 1, which contains all (sub)categories of the ICD-9.
In health care, diagnosis codes are used as a tool to group and identify diseases, disorders, symptoms, poisonings, adverse effects of drugs and chemicals, injuries and other reasons for patient encounters. Diagnostic coding is the translation of written descriptions of diseases, illnesses and injuries into codes from a particular classification.
hepatitis C virus: HD: Hodgkin disease Hemodialysis Huntington's disease: HDL: high-density lipoprotein: HDL-C: high-density lipoprotein-cholesterol HDN: hemolytic disease of the newborn: HDS: hemodynamically stable (i.e., not bleeding) HDU: high dependency unit: HDV: hepatitis D virus: HDW: Hemoglobin Distribution Width: H&E: hematoxylin and ...
The comprehensive metabolic panel, or chemical screen (CMP; CPT code 80053), is a panel of 14 blood tests that serves as an initial broad medical screening tool. The CMP provides a rough check of kidney function, liver function, diabetic and parathyroid status, and electrolyte and fluid balance, but this type of screening has its limitations.
Consensus conference statements recommended liver biopsy in the management of almost all patients with hepatitis C and B. [citation needed] Biopsy results show significant variability (up to 40% for fibrosis diagnosis) which can lead to a wrong diagnosis. The result depends on the representativity of the punctured sample. [4]
FibroTest has been evaluated in relation to liver biopsy (the current reference standard in liver disease assessment) in people with hepatitis C, hepatitis B, [1] alcoholic liver disease, [2] and non-alcoholic fatty liver disease. [3] They are most useful for cirrhosis and less useful for other stages of liver disease. [4]